CONFERENCE REPORT

ASCO 2011: Nancy Dawson Discusses Screening for PSA in Prostate Cancer

By Editors of the journal ONCOLOGY | August 5, 2011

Nancy Dawson, MD discusses PSA dynamics: the significance of PSA levels and PSA doubling time—the marker which currently provides the most information—and their usefulness in predicting metastatic disease and in counseling patients on their prognosis.

ASCO 2011

ASCO 2011: Cytoreductive Surgery plus HIPEC for Metastatic Colon Cancer
October 3, 2011

ASCO 2011: Ramaswami Govindan Discusses Current and Upcoming Lung Cancer Research
August 29, 2011

ASCO 2011: Dr. Antoni Ribas Discusses the Impact of 2 New Drugs for the Treatment of Metastatic Melanoma
August 19, 2011

ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials
August 12, 2011

ASCO 2011: Nancy Dawson Discusses Screening for PSA in Prostate Cancer
August 5, 2011

PUBLICATIONS


ONCOLOGY	ONCOLOGY: Nurse Edition	CANCER MANAGEMENT: A Multidisciplinary Approach

TOPIC INDEX

Cancer Types
Breast Breast (HER2+) Breast (Triple-Negative) CML Colorectal Gastrointestinal GIST Genitourinary Gynecologic Head & Neck	Hematology Kidney (Renal Cell) Leukemia Lung Lymphoma Melanoma Multiple Myeloma Ovarian Prostate Sarcoma
Supportive Care	More Topics
Bone Metastases End-of-Life Care Palliative Care	Ethics in Oncology Practice Management Practice & Policy

All Topics

ASCO 2011: Nancy Dawson Discusses Screening for PSA in Prostate Cancer

Join the Conversation